Myostatin blockade: A new way to enhance skeletal muscle repair in old age?

Molecular Therapy

Volumn 15, Issue 8, 2007, Pages 1407-1409

  Yablonka Reuveni, Zipora ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING AGENT; MYOSTATIN; MYOSTATIN ANTAGONIST; UNCLASSIFIED DRUG;

ADULTHOOD; AGING; CELL REGENERATION; DAILY LIFE ACTIVITY; DUCHENNE MUSCULAR DYSTROPHY; GENE DELETION; GENETIC MANIPULATION; HUMAN; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE INJURY; MUSCLE MASS; MUSCLE REGENERATION; NONHUMAN; NOTE; SATELLITE CELL; SKELETAL MUSCLE; STEM CELL; TISSUE REPAIR;

AGING; ANIMALS; HUMANS; MUSCLE, SKELETAL; REGENERATION; TRANSFORMING GROWTH FACTOR BETA;

EID: 34547119523     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300248     Document Type: Note

References (18)

1. Karakelides, H, Sreekumaran Nair, K (2005). Sarcopenia of aging and its metabolic impact. Curr Top Dev Biol 68: 123-148.
2. Zammit, PS, Partridge, TA, Yablonka-Reuveni, Z (2006). The skeletal muscle satellite cell: The stem cell that came in from the cold. J Histochem Cytochem 54: 1177-1191.
3. Conboy, IM, Conboy, MJ, Wagers, AJ, Girma, ER, Weissman, IL, Rando, TA (2005). Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433: 760-764.
4. Shefer, G, Van de Mark, DP, Richardson, JB, Yablonka-Reuveni, Z (2006). Satellite-cell pool size does matter: Defi ning the myogenic potency of aging skeletal muscle. Dev Biol 294: 50-66.
5. Siriett, V, Salerno, MS, Berry, C, Nicholas, G, Bower, R, Kambadur R et al. (2007). Antagonism of myostatin enhances muscle regeneration during sarcopenia. Mol Ther 15: 1463-1470.
6. Lee, SJ, McPherron, AC (2001). Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 98: 9306-9311.
7. McPherron, AC, Lee, SJ (1997). Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci USA 94: 12457-12461.
8. McPherron, AC, Lawler, AM, Lee, SJ (1997). Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature 387: 83-90.
9. Schuelke, M, Wagner, KR, Stolz, LE, Hubner, C, Riebel, T, Komen, W et al. (2004). Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350: 2682-2688.
10. Welle, S, Bhatt, K, Pinkert, CA, Tawil, R, Thornton, CA (2007). Muscle growth after postdevelopmental myostatin gene knockout. Am J Physiol Endocrinol Metab 292: E985-E991.
11. Zimmers, TA, Davies, MV, Koniaris, LG, Haynes, P, Esquela, AF, Tomkinson, KN et al. (2002). Induction of cachexia in mice by systemically administered myostatin. Science 296: 1486-1488.
12. Wagner, KR, McPherron, AC, Winik, N, Lee, SJ (2002). Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann Neurol 52: 832-836.
13. Bogdanovich, S, Krag, TOB, Barton, ER, Morris, LD, Whittemore, LA, Ahima, RS et al. (2002). Functional improvement of dystrophic muscle by myostatin blockade. Nature 420: 418-421.
14. Li, ZF, Shelton, GD, Engvall, E (2005). Elimination of myostatin does not combat muscular dystrophy in dy mice but increases postnatal lethality. Am J Pathol 166: 491-497.
15. Parsons, SA, Millay, DP, Sargent, MA, McNally, EM, Molkentin, JD (2006). Age-dependent effect of myostatin blockade on disease severity in a murine model of limb-girdle muscular dystrophy. Am J Pathol 168 1975-1985
16. McCroskery, S, Thomas, M, Platt, L, Hennebry, A, Nishimura, T, McLeay, L et al. (2005). Improved muscle healing through enhanced regeneration and reduced fi brosis in myostatin-null mice. J Cell Sci 118: 3531-3541.
17. Siriett, V, Platt, L, Salerno, MS, Ling, N, Kambadur, R, Sharma, M (2006). Prolonged absence of myostatin reduces sarcopenia. J Cell Physiol 209: 866-873.
18. Wagner, KR, Liu, X, Chang, X, Allen, RE (2005). Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci USA 102 2519-2524.